Pfizer and Moderna raise the price of their anticovid vaccines

American Pharmaceuticals Pfizer and Moderna the price of their anticovid vaccines rose by more than a quarter and a tenth, respectively, in the latest supply contracts to the European Union, the “Financial Times” newspaper said this Sunday.

The terms of the contracts, signed this year until 2023 for a total of 2.1 billion doses, were renegotiated after clinical studies indicated that the mRNA-type vaccines of these two companies had better efficacy rates than the cheaper ones from Oxford/AstraZeneca Y Johnson & Johnson, says the newspaper.

The price of a dose of the Pfizer preparation went from the current 15.50 euros to 19.50 euros, according to parts of the contract to which the FT has had access.


Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.